Skip to content

A study comparing two breathing in medicines to control heart rate and blood pressure during placement of a breathing tube under anesthesia

Comparison between nebulized dexmedetomidine and magnesium sulphate for attenuation of hemodynamic response to laryngoscopy and tracheal intubation: a prospective randomized controlled double blind study. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108933
Enrollment
135
Registered
2026-04-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Nebulization with dexmedetomidine : Participants will recieve calculated dose of dexmedetomidine at 1 microgram per kg in 5ml volume in nebulized form 15-20 minutes prior to induction

Sponsors

Department of Anesthesiology, IPGMER and SSKM Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 18 60 years of either sex, belonging to ASA physical status I and II, with Mallampati grade I and II, scheduled for elective surgery under general anesthesia requiring endotracheal intubation, with body mass index less than 30 kg/m , and willing to provide written informed consent.

Exclusion criteria

Exclusion criteria: Patients who do not provide consent for participation, those with ASA physical status other than I and II, Mallampati grade other than I and II, age less than 18 years or more than 60 years, body mass index (BMI) greater than 30 kg/m , known allergy to the study drugs (dexmedetomidine or magnesium sulphate), history of cardiovascular diseases such as ischemic heart disease, arrhythmias, tachycardia, bradycardia or uncontrolled hypertension, history of bronchial asthma, neuromuscular disorders, chronic alcohol intake or drug abuse, and pregnant patients will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
To Study the change of Heart Beat / Min as a primary parameter by the effect of nebulized dexmedetomidine and magnesium sulphate during laryngoscopy and intubation.Timepoint: Baseline (T0), post-nebulization (T1), 2 minutes (T2), 5 minutes (T3), and 10 minutes (T4) after tracheal intubation

Secondary

MeasureTime frame
Change in systolic blood pressure (SBP)Timepoint: Baseline (T0), post-nebulization (T1), 2 minutes (T2), 5 minutes (T3), and 10 minutes (T4) after intubation;Change in diastolic blood pressure (DBP)Timepoint: Baseline (T0), post-nebulization (T1), 2 minutes (T2), 5 minutes (T3), and 10 minutes (T4) after intubation;Change in mean arterial pressure (MAP)Timepoint: Baseline (T0), post-nebulization (T1), 2 minutes (T2), 5 minutes (T3), and 10 minutes (T4) after intubation;Incidence of intraoperative adverse events (bradycardia, hypotension, respiratory depression)Timepoint: Intraoperative period;Incidence and severity of postoperative sore throatTimepoint: Immediately after extubation, 2 hours, 6 hours, and 24 hours postoperatively

Countries

India

Contacts

Public ContactDr Bushra Khan

Institue of Post Graduate Medical Education and Reaserch and SSKM Hospital

rajat.choudhuri@gmail.com9874660960

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026